LAURA OEHLER: Open Payments
NPI 1508347766 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,785 in 60 payments from 20 companies in 2025. Trend: 2023 $1,462 · 2024 $2,365 · 2025 $1,785
Food & beverage: $1,785
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 12 | $293 |
| ABBVIE INC. | 8 | $241 |
| AstraZeneca Pharmaceuticals LP | 3 | $150 |
| GlaxoSmithKline, LLC. | 4 | $148 |
| Novo Nordisk Inc | 8 | $138 |
| Globus Medical, Inc. | 1 | $133 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Kowa Pharmaceuticals America, Inc. | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $67 |
Products named: TZIELD, VRAYLAR, AIRSUPRA, Senza, VOQUEZNA, Auvelity, SHINGRIX, ZORYVE.
Industry payments across TX — which companies pay providers there.
